A third caveat relates to the use of ghrelin-KO mice, which, because of long-term absence of ghrelin, could exhibit a phenotype reflective of potential compensatory developmental changes that alter the true effects of absent ghrelin action in the setting of insulin-induced hypoglycemia. The gene discussed is GHRL; the disease is Hypoglycemia.